ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Amalaki Extract

Also known as: Amalaki, Amla, Indian gooseberry, Phyllanthus emblica, Emblica officinalis

Overview

Amalaki extract is derived from the fruit of *Emblica officinalis*, a tree native to India and Southeast Asia, and is a cornerstone of traditional Ayurvedic medicine. It is primarily utilized as a dietary supplement due to its potent antioxidant, anti-inflammatory, and rejuvenating properties. The extract is increasingly recognized for its potential to support cardiovascular health, improve glucose metabolism, and reduce systemic inflammation. Research on Amalaki is evolving, with a growing body of evidence from randomized controlled trials (RCTs) and meta-analyses supporting its efficacy. It is commonly available in various forms, including powders, capsules, and liquid extracts, with standardized extracts being preferred for consistent delivery of active compounds.

Benefits

Amalaki extract offers several evidence-based benefits, particularly for metabolic and cardiovascular health. Meta-analyses of randomized controlled trials (RCTs) involving adults with dyslipidemia or type 2 diabetes consistently show that Amalaki supplementation significantly improves lipid profiles by reducing LDL cholesterol, VLDL cholesterol, and triglycerides, while increasing beneficial HDL cholesterol. Furthermore, it has been associated with statistically significant reductions in fasting blood glucose levels, especially in individuals with impaired glucose metabolism or type 2 diabetes. Amalaki also reduces C-reactive protein (CRP), a key marker of systemic inflammation, which contributes to its cardiovascular protective effects. These improvements in lipid and glucose parameters collectively reduce physiological risk factors for cardiovascular disease. Benefits typically manifest within 3 to 12 weeks of consistent supplementation. While further high-quality clinical validation is needed, secondary benefits such as antioxidant, hepatoprotective, and immunomodulatory effects have also been reported.

How it works

Amalaki's therapeutic effects are attributed to its rich composition of bioactive compounds, including vitamin C, tannins (notably emblicanin A and B), flavonoids, and various polyphenols. These compounds exert powerful antioxidant effects by scavenging free radicals and mitigating oxidative stress throughout the body. Its influence on lipid metabolism involves modulating enzymes crucial for cholesterol synthesis and clearance, leading to improved lipid profiles. The anti-inflammatory actions are mediated through the downregulation of pro-inflammatory cytokines and C-reactive protein. Additionally, Amalaki may enhance insulin sensitivity, thereby improving glucose uptake and utilization by cells. The effectiveness of Amalaki is dependent on the bioavailability of these active compounds, which can vary with the extract preparation, highlighting the importance of standardized extracts.

Side effects

Amalaki extract is generally considered safe and well-tolerated, with a low incidence of adverse effects reported in clinical trials. When side effects do occur, they are typically mild and may include transient gastrointestinal discomfort. Robust clinical trials have not reported significant drug interactions or contraindications. However, due to limited extensive research on specific populations, caution is advised for pregnant or lactating women, and use in these groups should be under medical supervision. While no severe adverse events have been widely documented, individuals with pre-existing medical conditions or those taking other medications should consult a healthcare professional before initiating supplementation to ensure safety and avoid potential interactions.

Dosage

Effective dosages of standardized Amalaki extract, as observed in clinical trials, typically range from 500 mg to 1000 mg daily. The duration of supplementation in studies has varied, with benefits observed over periods ranging from 3 to 12 weeks. There is no established maximum safe dose, and doses exceeding 1000 mg per day have not been extensively studied in randomized controlled trials. The timing of supplementation relative to meals has not been shown to significantly impact its efficacy. For consistent and reproducible results, it is recommended to use standardized extracts that specify the content of active components, such as vitamin C or total polyphenols, as this ensures a more reliable delivery of the beneficial compounds.

FAQs

Is Amalaki extract safe for long-term use?

Current evidence supports the safety of Amalaki for short-term use, typically up to 12 weeks. Data on its long-term safety beyond this period are limited, so caution is advised for extended use.

How soon can benefits be expected?

Improvements in lipid profiles and glucose parameters have been observed within 3 to 12 weeks of consistent Amalaki supplementation, according to clinical studies.

Can Amalaki replace conventional medications?

Amalaki extract may serve as an adjunct therapy to support health, but it should not replace prescribed medications or treatments without direct medical supervision.

Does the form of Amalaki matter?

Yes, standardized extracts are generally preferred over raw fruit or powders. They provide more reliable dosing and consistent levels of active compounds, ensuring better efficacy.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/36934568/ – This meta-analysis of randomized controlled trials (RCTs) found that Amalaki supplementation significantly reduced LDL cholesterol, triglycerides, and fasting blood glucose, while increasing HDL cholesterol in adults with dyslipidemia or type 2 diabetes. The study highlights Amalaki's potential for metabolic and cardiovascular health.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10251691/ – This meta-analysis, following Cochrane guidelines, demonstrated that Amalaki extract improved lipid profiles (LDL, VLDL, HDL, triglycerides) and reduced hsCRP in adults with cardiovascular disease risk factors. The findings support Amalaki's role in mitigating cardiovascular risk.
  • https://yijasm.in/pdf/Meenal_Lad_%20Review_Article_Page_13_17.pdf – This narrative review discusses the anti-inflammatory, hepatoprotective, and immunomodulatory properties of Amalaki. While not a quantitative synthesis, it provides valuable mechanistic insights into the broad therapeutic potential of the extract.
  • https://www.binasss.sa.cr/mar23/27.pdf – This source, likely related to the Setayesh et al. 2023 meta-analysis, reinforces the findings of significant reductions in LDL, triglycerides, glucose, and CRP, alongside an increase in HDL. It supports the efficacy of Amalaki in improving metabolic and cardiovascular markers.